vs
NovoCure Ltd（NVCR）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Rocket Lab Corp的季度营收约是NovoCure Ltd的1.0倍（$179.7M vs $174.1M），Rocket Lab Corp净利率更高（-29.5% vs -40.9%，领先11.4%），Rocket Lab Corp同比增速更快（35.7% vs 12.3%），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 7.6%）
NovoCure Ltd是一家全球肿瘤医疗企业，专注研发肿瘤治疗电场（TTFields）技术，推出可穿戴非侵入式癌症治疗设备，已获批用于胶质母细胞瘤、恶性胸膜间皮瘤、非小细胞肺癌等多个癌种，业务覆盖北美、欧洲及亚太地区。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
NVCR vs RKLB — 直观对比
营收规模更大
RKLB
是对方的1.0倍
$174.1M
营收增速更快
RKLB
高出23.4%
12.3%
净利率更高
RKLB
高出11.4%
-40.9%
两年增速更快
RKLB
近两年复合增速
7.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $174.1M | $179.7M |
| 净利润 | $-71.1M | $-52.9M |
| 毛利率 | 77.6% | 38.0% |
| 营业利润率 | — | -28.4% |
| 净利率 | -40.9% | -29.5% |
| 营收同比 | 12.3% | 35.7% |
| 净利润同比 | -107.3% | -1.1% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVCRRKLB
| Q1 26 | $174.1M | — | ||
| Q4 25 | $174.3M | $179.7M | ||
| Q3 25 | $167.2M | $155.1M | ||
| Q2 25 | $158.8M | $144.5M | ||
| Q1 25 | $155.0M | $122.6M | ||
| Q4 24 | $161.3M | $132.4M | ||
| Q3 24 | $155.1M | $104.8M | ||
| Q2 24 | $150.4M | $106.3M |
净利润NVCRRKLB
| Q1 26 | $-71.1M | — | ||
| Q4 25 | $-24.5M | $-52.9M | ||
| Q3 25 | $-37.3M | $-18.3M | ||
| Q2 25 | $-40.1M | $-66.4M | ||
| Q1 25 | $-34.3M | $-60.6M | ||
| Q4 24 | $-65.9M | $-52.3M | ||
| Q3 24 | $-30.6M | $-51.9M | ||
| Q2 24 | $-33.4M | $-41.6M |
毛利率NVCRRKLB
| Q1 26 | 77.6% | — | ||
| Q4 25 | 75.8% | 38.0% | ||
| Q3 25 | 73.2% | 37.0% | ||
| Q2 25 | 73.9% | 32.1% | ||
| Q1 25 | 75.1% | 28.8% | ||
| Q4 24 | 79.2% | 27.8% | ||
| Q3 24 | 77.2% | 26.7% | ||
| Q2 24 | 77.0% | 25.6% |
营业利润率NVCRRKLB
| Q1 26 | — | — | ||
| Q4 25 | -23.2% | -28.4% | ||
| Q3 25 | -21.5% | -38.0% | ||
| Q2 25 | -24.9% | -41.3% | ||
| Q1 25 | -24.4% | -48.3% | ||
| Q4 24 | -39.3% | -38.9% | ||
| Q3 24 | -20.7% | -49.5% | ||
| Q2 24 | -22.3% | -40.7% |
净利率NVCRRKLB
| Q1 26 | -40.9% | — | ||
| Q4 25 | -14.1% | -29.5% | ||
| Q3 25 | -22.3% | -11.8% | ||
| Q2 25 | -25.3% | -46.0% | ||
| Q1 25 | -22.1% | -49.5% | ||
| Q4 24 | -40.9% | -39.5% | ||
| Q3 24 | -19.7% | -49.6% | ||
| Q2 24 | -22.2% | -39.2% |
每股收益（稀释后）NVCRRKLB
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | $-0.09 | ||
| Q3 25 | $-0.33 | $-0.03 | ||
| Q2 25 | $-0.36 | $-0.13 | ||
| Q1 25 | $-0.31 | $-0.12 | ||
| Q4 24 | $-0.61 | $-0.11 | ||
| Q3 24 | $-0.28 | $-0.10 | ||
| Q2 24 | $-0.31 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $432.0M | $1.0B |
| 总债务越低越好 | — | $152.4M |
| 股东权益账面价值 | $330.7M | $1.7B |
| 总资产 | $787.9M | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资NVCRRKLB
| Q1 26 | $432.0M | — | ||
| Q4 25 | $93.5M | $1.0B | ||
| Q3 25 | $342.1M | $976.7M | ||
| Q2 25 | $149.6M | $688.1M | ||
| Q1 25 | $127.3M | $428.4M | ||
| Q4 24 | $163.8M | $419.0M | ||
| Q3 24 | $185.4M | $442.4M | ||
| Q2 24 | $164.8M | $496.8M |
总债务NVCRRKLB
| Q1 26 | — | — | ||
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $345.9M | ||
| Q4 24 | — | $345.4M | ||
| Q3 24 | — | $61.2M | ||
| Q2 24 | — | $64.2M |
股东权益NVCRRKLB
| Q1 26 | $330.7M | — | ||
| Q4 25 | $340.5M | $1.7B | ||
| Q3 25 | $341.3M | $1.3B | ||
| Q2 25 | $349.4M | $688.5M | ||
| Q1 25 | $362.0M | $431.3M | ||
| Q4 24 | $360.2M | $382.5M | ||
| Q3 24 | $360.8M | $419.8M | ||
| Q2 24 | $361.8M | $455.2M |
总资产NVCRRKLB
| Q1 26 | $787.9M | — | ||
| Q4 25 | $804.3M | $2.3B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | $1.2B | $1.6B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.2B | $1.2B |
负债/权益比NVCRRKLB
| Q1 26 | — | — | ||
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-114.2M |
| 自由现金流率自由现金流/营收 | — | -63.6% |
| 资本支出强度资本支出/营收 | — | 27.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-321.8M |
8季度趋势，按日历期对齐
经营现金流NVCRRKLB
| Q1 26 | — | — | ||
| Q4 25 | $-18.0M | $-64.5M | ||
| Q3 25 | $20.6M | $-23.5M | ||
| Q2 25 | $-15.9M | $-23.2M | ||
| Q1 25 | $-35.7M | $-54.2M | ||
| Q4 24 | $-3.5M | $-2.4M | ||
| Q3 24 | $10.4M | $-30.9M | ||
| Q2 24 | $-1.7M | $-13.0M |
自由现金流NVCRRKLB
| Q1 26 | — | — | ||
| Q4 25 | $-22.9M | $-114.2M | ||
| Q3 25 | $14.9M | $-69.4M | ||
| Q2 25 | $-21.4M | $-55.3M | ||
| Q1 25 | $-46.3M | $-82.9M | ||
| Q4 24 | $-12.4M | $-23.9M | ||
| Q3 24 | $-307.0K | $-41.9M | ||
| Q2 24 | $-13.2M | $-28.3M |
自由现金流率NVCRRKLB
| Q1 26 | — | — | ||
| Q4 25 | -13.1% | -63.6% | ||
| Q3 25 | 8.9% | -44.8% | ||
| Q2 25 | -13.5% | -38.3% | ||
| Q1 25 | -29.9% | -67.6% | ||
| Q4 24 | -7.7% | -18.1% | ||
| Q3 24 | -0.2% | -40.0% | ||
| Q2 24 | -8.8% | -26.7% |
资本支出强度NVCRRKLB
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | 27.6% | ||
| Q3 25 | 3.4% | 29.6% | ||
| Q2 25 | 3.5% | 22.2% | ||
| Q1 25 | 6.8% | 23.4% | ||
| Q4 24 | 5.5% | 16.3% | ||
| Q3 24 | 6.9% | 10.5% | ||
| Q2 24 | 7.6% | 14.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVCR
暂无分部数据
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
